Paid Clinical Trials for Malignant Solid Neoplasm

Showing 21 – 40 of 77 results

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Metastatic Malignant Solid Neoplasm

Other

Minnesota

Deadline:

12/01/2029

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm

Other

California

Deadline:

01/31/2028

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm

Other

Washington

Deadline:

03/31/2026

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

by CTG

in Malignant Solid Neoplasm, Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Locally Advanced Rectal Carcinoma, Locally Advanced Cervical Carcinoma

Other

California

Deadline:

07/20/2026

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm

Other

North Carolina

Deadline:

12/01/2026

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

by CTG

in Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain

Other

California

Deadline:

10/03/2026

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

by CTG

in Advanced Malignant Solid Neoplasm, Malignant Solid Neoplasm, Recurrent Hepatoblastoma, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

Other

Alabama

Deadline:

10/03/2026

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Carcinoma in Situ

Other

Alabama

Deadline:

03/31/2026

Patient Reported Symptom Control With THC or CBD Use

by CTG

in Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Cancer-Associated Pain

Other

Arizona

Deadline:

02/02/2027

Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery

by CTG

in Digestive System Carcinoma, Genitourinary System Carcinoma, Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm

Other

California

Deadline:

11/30/2026

PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

by CTG

in Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Chemotherapy-induced Peripheral Neuropathy

Other

Connecticut

Deadline:

02/28/2026

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

by CTG

in Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Tumor Lysis Syndrome

Other

Texas

Deadline:

07/31/2026

Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm

Other

California

Deadline:

01/01/2027

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm

Other

Minnesota

Deadline:

12/01/2035

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

by CTG

in Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm

Other

Washington

Deadline:

09/11/2026

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

by CTG

in Advanced Malignant Solid Neoplasm, Malignant Solid Neoplasm, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Metastatic Malignant Solid Neoplasm

Other

Texas

Deadline:

04/30/2026

Ex Vivo Expansion (ACT-X)

by CTG

in Healthy, Solid Tumor, Malignant Solid Neoplasm

Other

Florida

Deadline:

10/01/2028

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

by CTG

in Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Neuropathy, COVID-19 Infection

Other

Texas

Deadline:

04/30/2027

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

by CTG

in Malignant Solid Neoplasm

Other

Arizona

Deadline:

02/06/2028

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

by CTG

in Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Renal Cell Carcinoma, Melanoma

Other

California

Deadline:

02/03/2027

Load more All clinical trials loaded.

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Patient Reported Symptom Control With THC or CBD Use

Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery

PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Ex Vivo Expansion (ACT-X)

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Malignant Solid Neoplasm

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps